The Patent Finder

Sentoclone International AB

Also on record
Records under this name other than the patents Sentoclone International AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Sentoclone International AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,211,424Method for treating malignant melanoma
Lapsed on the fee record
Ended Jul 3, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2020USPTO record
US 8,211,425Method for treating disseminated cancer
Lapsed on the fee record
Ended Jul 3, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2020USPTO record
US 8,206,702Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer
Lapsed on the fee record
Ended Jun 26, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 26, 2020USPTO record
US 8,101,173Method for treating urinary bladder cancer
Lapsed on the fee record
Ended Jan 24, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 24, 2020USPTO record
US 8,007,785Method for treating colon cancer with tumour-reactive T-lymphocytes
Lapsed on the fee record
Ended Aug 30, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 30, 2019USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited